Randomized Controlled Trial of a Diabetes Self-Management SmartPhone App for Patients with Type 1 Diabetes
|
If you are the presenter of this abstract (or if you cite this abstract in a talk or on a poster), please show the QR code in your slide or poster (QR code contains this URL). |
Abstract
Background: Currently there are over 17,000 health-related smartphone apps available for consumers. Increasing numbers of people are using these apps to self-manage chronic diseases, such as diabetes. Despite the health care services available, many Type 1 Diabetes patients have poor glycemic control. These poor results may be attributed to the continued burden and complexity of the disease, such as applying the calculation of insulin doses, keeping a logbook and having regular consultations with their health care provider. Furthermore, health care providers often face a lack of information on which to base their advice regarding the patient’s insulin dose adjustments during consultations.
Objective: To examine the effectiveness of a freely available diabetes-related smartphone app combined with support from a Credentialed Diabetes Educator to improve self-management, glycemic control and quality of life in poorly controlled patients with Type 1 diabetes.
Methods: In a six-month intervention, followed by a three-month follow up, adult patients (n = 72) with type 1 diabetes (>6 months), and poor glycemic control (HbA1c ≥7.5%), were randomized to usual care - quarterly visits to health care provider (control group) or usual care added with the use of a smartphone app (Glucose Buddy) with weekly text-message feedback from a Credentialed Diabetes Educator (intervention group). The primary outcome measure was the improvement in glycemic control assessed glycosylated haemoglobin levels (HbA1c). Diabetes-related self-efficacy, self-care activities and quality of life were also measured. All measures were collected at baseline and every 3-months over the 9-month study for both groups. The engagement of patients in the intervention group was measured in terms of usage of the smartphone app, and text-message communication with the Credentialed Diabetes Educator.
Results: Linear mixed modelling analysis employing intention-to-treat principles showed a significant time by group interaction with glycemic control (HbA1c), F(1, 246.00) = 20.07, p <.001. The intervention group significantly decreased HbA1c from baseline (M = 9.08 ± 1.18) to nine month follow-up (7.80 ± 0.75), compared to the control group (baseline M = 8.47 ± 0.86, follow-up M = 8.58 ± 1.16). No significant change over time was found in either group in relation to self-efficacy, self-care activities and quality of life. Over the 6-month study period, intervention participants received 1714 text messages (M = 2 per week) and sent 559 text messages (M = 0.6 per week) to the Credentialed Diabetes Educator. Intervention participants logged 24,720 (M = 28.6 per week) measures (blood glucose, insulin, diet and physical activity) on the Glucose Buddy app over the 6-month intervention period. Linear regression analysis revealed that engagement of intervention participants as measured by number of logs on the smartphone app and text-messages sent to Credentialed Diabetes Educator was not significantly related to HbA1c change scores.
Conclusion: In adjunct with usual care, the use of a diabetes-related smartphone app combined with weekly text-message support from a health care provider can significantly improve glycemic control in adults with Type 1 Diabetes.
Objective: To examine the effectiveness of a freely available diabetes-related smartphone app combined with support from a Credentialed Diabetes Educator to improve self-management, glycemic control and quality of life in poorly controlled patients with Type 1 diabetes.
Methods: In a six-month intervention, followed by a three-month follow up, adult patients (n = 72) with type 1 diabetes (>6 months), and poor glycemic control (HbA1c ≥7.5%), were randomized to usual care - quarterly visits to health care provider (control group) or usual care added with the use of a smartphone app (Glucose Buddy) with weekly text-message feedback from a Credentialed Diabetes Educator (intervention group). The primary outcome measure was the improvement in glycemic control assessed glycosylated haemoglobin levels (HbA1c). Diabetes-related self-efficacy, self-care activities and quality of life were also measured. All measures were collected at baseline and every 3-months over the 9-month study for both groups. The engagement of patients in the intervention group was measured in terms of usage of the smartphone app, and text-message communication with the Credentialed Diabetes Educator.
Results: Linear mixed modelling analysis employing intention-to-treat principles showed a significant time by group interaction with glycemic control (HbA1c), F(1, 246.00) = 20.07, p <.001. The intervention group significantly decreased HbA1c from baseline (M = 9.08 ± 1.18) to nine month follow-up (7.80 ± 0.75), compared to the control group (baseline M = 8.47 ± 0.86, follow-up M = 8.58 ± 1.16). No significant change over time was found in either group in relation to self-efficacy, self-care activities and quality of life. Over the 6-month study period, intervention participants received 1714 text messages (M = 2 per week) and sent 559 text messages (M = 0.6 per week) to the Credentialed Diabetes Educator. Intervention participants logged 24,720 (M = 28.6 per week) measures (blood glucose, insulin, diet and physical activity) on the Glucose Buddy app over the 6-month intervention period. Linear regression analysis revealed that engagement of intervention participants as measured by number of logs on the smartphone app and text-messages sent to Credentialed Diabetes Educator was not significantly related to HbA1c change scores.
Conclusion: In adjunct with usual care, the use of a diabetes-related smartphone app combined with weekly text-message support from a health care provider can significantly improve glycemic control in adults with Type 1 Diabetes.
Medicine 2.0® is happy to support and promote other conferences and workshops in this area. Contact us to produce, disseminate and promote your conference or workshop under this label and in this event series. In addition, we are always looking for hosts of future World Congresses. Medicine 2.0® is a registered trademark of JMIR Publications Inc., the leading academic ehealth publisher.

This work is licensed under a Creative Commons Attribution 3.0 License.